NAVIDEA BIOPHARMACEUTICALS I (NAVB)
US63937X2027 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to NAVB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 6446.85% above the current price.
NAVB was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NAVB.
In the previous month the buy percentage consensus was at a similar level.
NAVB was analyzed by 7 analysts. More opinions would make the average more meaningful.